Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Medtronic
Baxter
Cantor Fitzgerald
Accenture
Covington
Cipla
Moodys

Generated: July 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018998

« Back to Dashboard

NDA 018998 describes VASOTEC, which is a drug marketed by Biovail Labs Intl and Valeant Pharms North and is included in two NDAs. It is available from five suppliers. Additional details are available on the VASOTEC profile page.

The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
Summary for 018998
Tradename:VASOTEC
Applicant:Valeant Pharms North
Ingredient:enalapril maleate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 018998
Medical Subject Heading (MeSH) Categories for 018998
Suppliers and Packaging for NDA: 018998
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VASOTEC enalapril maleate TABLET;ORAL 018998 NDA Valeant Pharmaceuticals North America LLC 0187-0140 N 0187-0140-30
VASOTEC enalapril maleate TABLET;ORAL 018998 NDA Valeant Pharmaceuticals North America LLC 0187-0140 N 0187-0140-90

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Dec 24, 1985TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Dec 24, 1985TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Dec 24, 1985TE:ABRLD:Yes

Expired US Patents for NDA 018998

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North VASOTEC enalapril maleate TABLET;ORAL 018998-001 Dec 24, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North VASOTEC enalapril maleate TABLET;ORAL 018998-003 Dec 24, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North VASOTEC enalapril maleate TABLET;ORAL 018998-005 Jul 26, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North VASOTEC enalapril maleate TABLET;ORAL 018998-002 Dec 24, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
Chubb
Mallinckrodt
Harvard Business School
Cipla
Dow
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.